Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Optimind Pharma Corp. (OMND.CN)

Optimind Pharma Corp. (OMND.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 516
  • Shares Outstanding, K 103,148
  • Annual Sales, $ 118 K
  • Annual Income, $ -216 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.29
  • Price/Sales 4.33
  • Price/Cash Flow 20.10
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings $0.00 on 10/30/25
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING:

    SIC-2834 Pharmaceutical Preparations

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0050 unch
on 08/22/25
0.0100 -50.00%
on 08/18/25
-0.0050 (-50.00%)
since 07/22/25
3-Month
0.0050 unch
on 08/22/25
0.0100 -50.00%
on 08/18/25
-0.0050 (-50.00%)
since 05/22/25
52-Week
0.0050 unch
on 08/22/25
0.0100 -50.00%
on 08/18/25
unch (unch)
since 08/22/24

Most Recent Stories

More News
Optimind Pharma Announces Termination of Letter of Intent

Toronto, Ontario--(Newsfile Corp. - September 4, 2025) - Optimind Pharma Corp. (CSE: OMND) (the "Optimind" or the "Company") announces that its previously announced non-binding letter of intent dated March...

OMND.CN : 0.0050 (unch)
Optimind Pharma Enters into Letter of Intent with Monjin to Acquire AI Business

Toronto, Ontario--(Newsfile Corp. - March 24, 2025) - Optimind Pharma Corp. (CSE: OMND) (the "Optimind" or the "Company") announces that it has entered into a non-binding letter of intent dated March 18,...

OMND.CN : 0.0050 (unch)
Optimind Pharma Closes Second Tranche of Private Placement

Toronto, Ontario--(Newsfile Corp. - July 29, 2024) - Optimind Pharma Corp. (CSE: OMND) ("Optimind" or the "Company") announces it has closed the second trance of its previously announced private placement....

OMND.CN : 0.0050 (unch)
Optimind Pharma Closes First Tranche of Private Placement

Toronto, Ontario--(Newsfile Corp. - July 8, 2024) - Optimind Pharma Corp. (CSE: OMND) ("Optimind" or the "Company") announces it has closed the first trance of its previously announced private placement....

OMND.CN : 0.0050 (unch)
Optimind Pharma - Private Placement

Toronto, Ontario--(Newsfile Corp. - July 3, 2024) - Optimind Pharma Corp. (CSE: OMND) (the "Optimind" or the "Company") announces a proposed private placement. The Company intends to issue up to 10,000,000...

OMND.CN : 0.0050 (unch)
Optimind Pharma Corp. Announces Grant of Options

Toronto, Ontario--(Newsfile Corp. - March 10, 2023) - Optimind Pharma Corp. (CSE: OMND) (the "Company") wishes to announce that pursuant to its stock option plan, it has granted stock options to its directors,...

OMND.CN : 0.0050 (unch)
Stocks in play: Optimind Pharma Corp

Announces today its acquisition of MindSetting Institute, a leader in psychedelic enhanced therapy training ...

OMND.CN : 0.0050 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Optimind Pharma Corp, through its clinic, specializes in prescribing medical cannabis and other alternative treatments for various medical ailments. It offers psychedelic-like therapies at its clinic, helping people suffering from PTSD, anxiety, depression, and other mental illnesses and disabilities...

See More

Key Turning Points

3rd Resistance Point 0.0050
2nd Resistance Point 0.0050
1st Resistance Point 0.0050
Last Price 0.0050
1st Support Level 0.0050
2nd Support Level 0.0050
3rd Support Level 0.0050

See More

52-Week High 0.0100
Fibonacci 61.8% 0.0081
Fibonacci 50% 0.0075
Fibonacci 38.2% 0.0069
Last Price 0.0050
52-Week Low 0.0050

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar